Cargando…
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
BNCT is a radiotherapeutic method for cancer treatment that uses tumor-targeting (10)B-compounds. BNCT for cutaneous melanoma using BPA, a phenylalanine derivative, was first initiated by Mishima et al. in 1987. This article reviews the radiobiological basis of melanoma control and damage to normal...
Autor principal: | Fukuda, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616259/ https://www.ncbi.nlm.nih.gov/pubmed/34831103 http://dx.doi.org/10.3390/cells10112881 |
Ejemplares similares
-
Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
por: Hiratsuka, Junichi, et al.
Publicado: (2020) -
Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with (10)B-Borocaptate Sodium (BSH) and (10)B-Paraboronophenylalanine (BPA)
por: Fukuda, Hiroshi
Publicado: (2021) -
Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
por: Morris, G. M., et al.
Publicado: (1997) -
Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
por: Kondo, Natsuko, et al.
Publicado: (2020) -
Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023)